BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This highly advanced material comprises 17-allylamino-17-demethoxygeldanamycin loaded anti-CD90 targeted magnetic thermosensitive liposomes (CD90@17-AAG/TMs). The complex architecture features a thermosensitive lipid vesicle encapsulating superparamagnetic iron oxide nanoparticles within its aqueous compartments and the hydrophobic hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) within its bilayer, while the outer surface is functionalized with anti-CD90 monoclonal antibodies. When exposed to an external alternating magnetic field or elevated temperatures matching the lipid phase transition threshold in a laboratory assay, the magnetic nanoparticles generate localized hyperthermia, triggering a sharp phase change in the bilayer that accelerates drug release. The resulting immunoliposomes provide a multi-responsive model for studying targeted, thermally triggered mass transport phenomena.
Source
Custom synthesis
Functional Group
Anti-CD90 antibody; 17-AAG; Magnetic component
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.